Press releases
Read more:
Categories
2026
NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, WHETHER DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, BELARUS, HONG KONG, JAPAN, CANADA...
2026-11-13 08:38
NANOLOGICA ANNOUNCES CONFIRMED GUARANTEE COMMITMENT IN CONNECTION WITH ONGOING RIGHTS ISSUE
NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, WHETHER DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, BELARUS, HONG KONG, JAPAN, CANADA...
2026-11-11 15:13
NANOLOGICA ANNOUNCES NOMINATION COMMITTEE FOR THE ANNUAL GENERAL MEETING 2027
Regulatory
In accordance with the current nomination committee instructions, the chairman of the board has contacted Nanologica's three largest shareholders...
On October 23, 2026, Nanologica AB (publ) announced that Mark Quick has been appointed as the new CEO, provided that the Swedish Companies Registration...
2026-11-02 09:49
NANOLOGICA PUBLISHES INFORMATION DOCUMENT REGARDING RIGHTS ISSUE OF UNITS
Regulatory
NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, BELARUS, HONG KONG, JAPAN, CANADA, NEW ZEALAND...
The shareholders of Nanologica AB (publ), org.nr 556664-5023 (the "Company") are hereby invited to attend the Extraordinary General Meeting to...
2026-10-23 08:06
NANOLOGICA RESOLVES ON A PARTIALLY GUARANTEED RIGHTS ISSUE OF UNITS OF APPX. SEK 110.5 MILLION WITH AN OVERSUBSCRIPTION OPTION OF AN ADDITIONAL SEK 10 MILLION
Regulatory
MAR
The Board of Directors of Nanologica AB (publ) ("Nanologica" or the "Company") has today, based on the authorization granted by the...
2026-10-23 07:37
NANOLOGICA UPDATES STRATEGY AND APPOINTS NEW CEO TO DRIVE COMMERCIAL GROWTH AND PROFITABILITY
Regulatory
MAR
Nanologica AB has updated its strategy focusing on accelerating commercial growth, broadening the offering, and increasing focus on North America and Europe...
FINANCIAL SUMMARY SIGNIFICANT EVENTS DURING THE SECOND QUARTER SIGNIFICANT EVENTS AFTER THE END OF THE PERIOD CONTINUED STRENGTHENED COMMERCIAL POSITIONThe...
Nanologica's interim report for Q2 2026 will be published on Monday 31 August, instead of 20 August as previously announced. As a result of the acquisition...